Attached files
| file | filename |
|---|---|
| EX-10.64 - EX-10.64 - CytoDyn Inc. | d923315dex1064.htm |
| EX-32 - EX-32 - CytoDyn Inc. | d923315dex32.htm |
| EX-31.2 - EX-31.2 - CytoDyn Inc. | d923315dex312.htm |
| EX-31.1 - EX-31.1 - CytoDyn Inc. | d923315dex311.htm |
| EX-24 - EX-24 - CytoDyn Inc. | d923315dex24.htm |
| EX-21 - EX-21 - CytoDyn Inc. | d923315dex21.htm |
| EX-10.63 - EX-10.63 - CytoDyn Inc. | d923315dex1063.htm |
| EX-10.62 - EX-10.62 - CytoDyn Inc. | d923315dex1062.htm |
| EX-10.58 - EX-10.58 - CytoDyn Inc. | d923315dex1058.htm |
| EX-10.43 - EX-10.43 - CytoDyn Inc. | d923315dex1043.htm |
| EX-10.42 - EX-10.42 - CytoDyn Inc. | d923315dex1042.htm |
| EX-10.16 - EX-10.16 - CytoDyn Inc. | d923315dex1016.htm |
| EX-4.1 - EX-4.1 - CytoDyn Inc. | d923315dex41.htm |
| EX-3.1 - EX-3.1 - CytoDyn Inc. | d923315dex31.htm |
| 10-K - 10-K - CytoDyn Inc. | d923315d10k.htm |
Exhibit 23
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (333-206813 and 333-223884 and 333-237490) and Registration Statements Form S-3 (Nos. 333-213866 and 333-228991 and 333-223195 and 333-223563 and 333-233526 and 333-236198) of our report dated August 14, 2020, with respect to the consolidated financial statements of CytoDyn Inc., included in this Annual Report on Form 10-K for the year ended May 31, 2020. Our report on the consolidated financial statements contains an explanatory paragraph regarding CytoDyn Inc.’s ability to continue as a going concern.
| /s/ Warren Averett, LLC |
| Birmingham, Alabama |
| August 14, 2020 |